January 02, 2026

Risk of Liver Cancer With Oral Contraceptive Use

In a UK population-based study reported in The Lancet Oncology, Watling et al examined the relationship between ever use vs never use of oral contraceptives and the risk of liver cancer. Some findings...

The ASCO Post

December 23, 2025

FDA OKs First Oral GLP-1 for Obesity

An oral GLP-1 option entered obesity care with outcomes similar to injectable therapy.

Conexiant

December 16, 2025

Saturated Fat Benefits Vary by Risk

New systematic review finds cardiovascular benefits only in high-risk patients, challenges blanket dietary restrictions

Conexiant

December 16, 2025

Medical Oddities: The Smurf-Hued Health Trend  

Old dyes, new diets, lonely algorithms, stubborn viruses, and what a coffee cup might do for bones, this week.

Conexiant

December 12, 2025

Autism's 3-Hit Model Targets Mitochondria

Three necessary metabolic disruptions converge on cell danger response, suggesting prevention opportunities.

Conexiant

December 11, 2025

GLP-1 drugs pose no cancer risk, review finds

A large systematic review and meta-analysis was limited by a median follow-up of 70 weeks.

Conexiant

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 10, 2025

Medical Oddities: Hot Flashes, Prepare to Be Hypnotized

Your weekly grab bag: mouthwash spice, hypnotic cool-downs, muscle tea, fiber fixes, telomere buzz.

Conexiant

December 10, 2025

PFAS Exposure Tied to Hormone Disruption

Growing evidence links even low-level PFAS exposure to endocrine disruption, with a new study identifying n-PFOS as a leading driver of risk among women.

Conexiant